Showing results (101-110 of 324) with videos related to
Sort By:
Pageof 33
Leukemia & Lymphoma|August 21, 2024
Reduced prognostic value of beta-2-microglobulin for time to first treatment in CLL patients with compromised kidney functionJan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.The International Journal of Clinical and Experimental Hypnosis|February 20, 2016
Effectiveness of Self-Hypnosis on the Relief of Experimental Dental Pain: A Randomized TrialThomas Gerhard Wolf, Dominik Wolf, Dagna Below, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Bosutinib: A Potent Second-Generation Tyrosine Kinase InhibitorSusanne Isfort, Martina Crysandt, Deniz Gezer, et al.Therapeutic Advances in Hematology|August 4, 2022
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case reportJan-Paul Bohn, Anna Fiala, Sebastian Bachmann, et al.Journal of Leukocyte Biology|July 22, 2025
Decreased HLA-DR+CD3+ T cells three months after allogeneic stem cell transplantation predict severe chronic GvHD and transplant-related mortalityStefan Koeck, Gabriele Hetzenauer, Ines Peschel-Schaar, et al.Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.Anticancer Research|December 1, 2022
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 YearsNormann Steiner, Paula Schober, Wolfgang Willenbacher, et al.Human Brain Mapping|September 17, 2013
Age-related increases in Stroop interference: delineation of general slowing based on behavioral and white matter analysesDominik Wolf, Lisa Zschutschke, Armin Scheurich, et al.Blood|December 20, 2014
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitorsPeter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, et al.Pageof 33